The intersection of virus infection and liver disease: A comprehensive review of pathogenesis, diagnosis, and treatment

Author:

Ren Meng12ORCID,Lu Chenxia23ORCID,Zhou Mingwei4ORCID,Jiang Xiaobing4ORCID,Li Xiaodong123ORCID,Liu Ningning4ORCID

Affiliation:

1. Clinical College of Traditional Chinese Medicine Hubei University of Chinese Medicine Wuhan China

2. Institute of Liver Diseases, Hubei Key Laboratory of Theoretical and Applied Research of Liver and Kidney in Traditional Chinese Medicine Hubei Provincial Hospital of Traditional Chinese Medicine Wuhan China

3. Institute of Liver Diseases Hubei Province Academy of Traditional Chinese Medicine Wuhan China

4. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology Chinese Academy of Sciences Beijing China

Abstract

AbstractLiver disease represents a significant global burden, placing individuals at a heightened risk of developing cirrhosis and liver cancer. Viral infections act as a primary cause of liver diseases on a worldwide scale. Infections involving hepatitis viruses, notably hepatitis B, C, and E viruses, stand out as the most prevalent contributors to acute and chronic intrahepatic adverse outcome, although the hepatitis C virus (HCV) can be effectively cured with antiviral drugs, but no preventative vaccination developed. Hepatitis B virus (HBV) and HCV can lead to both acute and chronic liver diseases, including liver cirrhosis and hepatocellular carcinoma (HCC), which are principal causes of worldwide morbidity and mortality. Other viruses, such as Epstein–Barr virus (EBV) and cytomegalovirus (CMV), are capable of causing liver damage. Therefore, it is essential to recognize that virus infections and liver diseases are intricate and interconnected processes. A profound understanding of the underlying relationship between virus infections and liver diseases proves pivotal in the effective prevention, diagnosis, and treatment of these conditions. In this review, we delve into the mechanisms by which virus infections induce liver diseases, as well as explore the pathogenesis, diagnosis, and treatment of liver diseases.This article is categorized under: Infectious Diseases > Biomedical Engineering

Publisher

Wiley

Reference102 articles.

1. Hepatocellular carcinoma

2. Vera G. Amandeep K. Krishna K. Saifuddin K. Joyeta D. Jacob V. &Anadi M.(2023).Hepatitis B surface antigen loss rate and safety and discontinuations with pegylated interferon alpha in chronic hepatitis B virus infection a systematic review. The International Liver Congress™EASL European Association for the Study of the Liver June 21‐24 2023.https://www.natap.org/2023/EASL/EASL_105.htm

3. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3